Literature DB >> 1830359

Insertional inactivation of the Staphylococcus aureus beta-toxin by bacteriophage phi 13 occurs by site- and orientation-specific integration of the phi 13 genome.

D Coleman1, J Knights, R Russell, D Shanley, T H Birkbeck, G Dougan, I Charles.   

Abstract

Lysogenization of Staphylococcus aureus by the serotype F converting bacteriophage phi 13 results in loss of beta-toxin expression. Sequence analysis of the S. aureus beta-toxin gene (hlb), the attachment site (attP)-containing region of phi 13 DNA and the chromosome/bacteriophage DNA junctions of a phi 13 lysogen, revealed that the molecular mechanism of loss of beta-toxin expression was due to insertion of the phi 13 genome into the 5' end of hlb. The insertion site (attB) within hlb contained a 14 base pair core sequence in common with attP and both ends of the integrated linear prophage genome of a phi 13 lysogen. These findings indicate that integration of the phi 13 genome into hlb is site- and orientation-specific.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1830359     DOI: 10.1111/j.1365-2958.1991.tb00768.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  35 in total

1.  MM1, a temperate bacteriophage of the type 23F Spanish/USA multiresistant epidemic clone of Streptococcus pneumoniae: structural analysis of the site-specific integration system.

Authors:  E Gindreau; R López; P García
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

3.  Structure and biological activities of beta toxin from Staphylococcus aureus.

Authors:  Medora Huseby; Ke Shi; C Kent Brown; Jeff Digre; Fikre Mengistu; Keun Seok Seo; Gregory A Bohach; Patrick M Schlievert; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

5.  Construction of an integration-proficient vector based on the site-specific recombination mechanism of enterococcal temperate phage phiFC1.

Authors:  Hee-Youn Yang; Young-Woo Kim; Hyo-Ihl Chang
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

6.  Emergence of hospital- and community-associated panton-valentine leukocidin-positive methicillin-resistant Staphylococcus aureus genotype ST772-MRSA-V in Ireland and detailed investigation of an ST772-MRSA-V cluster in a neonatal intensive care unit.

Authors:  Gráinne I Brennan; Anna C Shore; Suzanne Corcoran; Sarah Tecklenborg; David C Coleman; Brian O'Connell
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

7.  Molecular fingerprinting of Staphylococcus aureus from bone and joint infections.

Authors:  C Luedicke; P Slickers; R Ehricht; S Monecke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-26       Impact factor: 3.267

8.  Prevalence and Genomic Structure of Bacteriophage phi3 in Human-Derived Livestock-Associated Methicillin-Resistant Staphylococcus aureus Isolates from 2000 to 2015.

Authors:  Sarah van Alen; Britta Ballhausen; Ursula Kaspar; Robin Köck; Karsten Becker
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

9.  Characterization of the lactococcal temperate phage TP901-1 and its site-specific integration.

Authors:  B Christiansen; M G Johnsen; E Stenby; F K Vogensen; K Hammer
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

10.  Characterization of genetic elements required for site-specific integration of the temperate lactococcal bacteriophage phi LC3 and construction of integration-negative phi LC3 mutants.

Authors:  D Lillehaug; N K Birkeland
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.